Craft

Select Medical

Stock Price

$33.1

2024-10-29

Market Capitalization

$4.3 B

2024-10-29

Revenue

$5.5 B

FY, 2025

Select Medical Summary

Company Summary

Overview
Select Medical is a company specializing in hospital and rehabilitative patient care. It operates through four business segments: critical illness recovery hospital, rehabilitation hospital, outpatient rehabilitation, and Concentra. The critical illness recovery hospital segment consists of hospitals designed to serve the needs of patients recovering from critical illnesses, often with complex medical needs. The rehabilitation hospital segment includes hospitals designed to serve patients that require intensive physical rehabilitation care. The outpatient rehabilitation segment incorporates clinics that provide physical, occupational, and speech rehabilitation services. The Concentra segment consists of occupational health centers and contract services provided at employer worksites that deliver occupational medicine, physical therapy, and consumer health services.
Type
Public
Status
Active
Founded
1996
HQ
Mechanicsburg, PA, US | view all locations
Website
https://www.selectmedical.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • David S. Chernow

    David S. Chernow, President & CEO

  • Martin F. Jackson

    Martin F. Jackson, Executive Vice President & Chief Financial Officer

  • Scott A. Romberger

    Scott A. Romberger, Senior Vice President, Controller & Chief Accounting Officer

  • John A. Saich

    John A. Saich, Executive Vice President & Chief Administrative Officer

Operating MetricsView all

Onsite Clinics (Concentra)

147
8.9%

Q3, 2022

Number of Visits (Outpatient Rehabilitation)

2.4M
2.5%

Q3, 2022

Number of Visits (Concentra)

3.3M
1.5%

Q3, 2022

LocationsView all

1 location detected

  • Mechanicsburg, PA HQ

    United States

    4714 Gettysburg Rd

Select Medical Financials

Summary Financials

Revenue (Q1, 2026)
$1.4B
Net income (Q1, 2026)
$63.8M
Cash (Q1, 2026)
$25.7M
EBIT (Q1, 2026)
$98.4M
Enterprise value
$7.3B

Footer menu